4C MR Therapy Could Be Safer Than Other TMVR Approaches
from Cardiovascular Business
A new mitral regurgitation (MR) therapy designed to treat patients with structural heart disease was shown to be a safer treatment option than other transcatheter mitral valve replacement (TMVR). The valve, designed by 4C Medical Technologies in Brooklyn Park, Minnesota, is the first MR therapy that preserves the native mitral valve and left ventricle using a supra-annular, atrial-only fixation technology.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063